Announced Sat, 12 Sept, 2026 · 12:33 IST
Lords Mark investor call: FY27 revenue guided at 1550 cr, 20.8% EBITDA margin
Mgmt Guided Margin ImprovementOrder Pipeline DisclosedAnalyst Day Multiyear TargetsInvestor Communications View source PDFExplain this filing
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.5%1-day move
₹82.50
prior close
₹82.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0-0.6-0.6+0.0+1.5+3.2+7.8+13.3+15.0+11.8+2.1———
Up moveDown movePending
AI summary
Lords Mark held an investor call on 10 Sep 2026. FY27 revenue guided at 1550 cr with 20.8% EBITDA and 12.8% PAT; FY28 projected at 2100 cr with 23-24% EBITDA. Renewable energy has 2000 cr confirmed orders through 2030. Net debt to EBITDA improved from 6.7x to 1.2x. Recently listed via reverse merger, yet to meet minimum public shareholding. Plans include spinning off renewable energy, rebranding as Lords Med, and 50 dialysis centers by March 2027.
Likely market impact
Positive: revenue growth and margin expansion backed by 2000 cr renewable order book. Risks: reverse merger, MPS non-compliance, and execution.